Search filters

List of works by Susan Halabi

9-Nitrocamptothecin as second line chemotherapy for men with progressive, metastatic, hormone refractory prostate cancer: Results of the CALGB 99901.

scientific article published in September 2004

A Molecular Model for Predicting Overall Survival in Patients with Metastatic Clear Cell Renal Carcinoma: Results from CALGB 90206 (Alliance).

scientific article published on 8 September 2015

A Simple Method for Deriving the Confidence Regions for the Penalized Cox's Model via the Minimand Perturbation

scientific article published on 18 May 2016

A Systematic Review and Recommendation for Reporting of Surrogate Endpoint Evaluation Using Meta-analyses

scientific article published on 06 February 2019

A min-max combination of biomarkers to improve diagnostic accuracy

scientific article

A novel test to compare two treatments based on endpoints involving both nonfatal and fatal events.

scientific article published on 20 April 2015

A pharmacodynamic study of rapamycin in men with intermediate- to high-risk localized prostate cancer

scientific article

A phase 2 multimodality trial of docetaxel/prednisone with sunitinib followed by salvage radiation therapy in men with PSA recurrent prostate cancer after radical prostatectomy.

scientific article

A phase 2 study of estramustine, docetaxel, and bevacizumab in men with castrate-resistant prostate cancer: results from Cancer and Leukemia Group B Study 90006.

scientific article

A phase II study of estramustine, docetaxel, and carboplatin with granulocyte-colony-stimulating factor support in patients with hormone-refractory prostate carcinoma: Cancer and Leukemia Group B 99813.

scientific article

A phase II study of estramustine, docetaxel, and exisulind in patients with hormone- refractory prostate cancer: results of cancer and leukemia group B trial 90004.

scientific article published in September 2008

A phase II study of gemcitabine and capecitabine in metastatic renal cancer: a report of Cancer and Leukemia Group B protocol 90008

scientific article published on 01 September 2006

A phase II trial of cisplatin, fixed dose-rate gemcitabine and gefitinib for advanced urothelial tract carcinoma: results of the Cancer and Leukaemia Group B 90102.

scientific article published on 8 October 2007

A phase II trial of temsirolimus in men with castration-resistant metastatic prostate cancer

scientific article

A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer

scientific article (publication date: 6 March 2003)

A tailored intervention to aid decision-making about hormone replacement therapy

scientific article published on 01 July 2002

Abstract 646: Liquid biopsy transcriptomics identify pathways associated with poor outcomes and immune phenotypes in men with mCRPC

scientific article published in 2022

Activities and accomplishments of the cancer and leukemia group B genitourinary committee.

scientific article

Adjusting for misclassification in a stratified biomarker clinical trial.

scientific article

Adjustment on the Type I Error Rate for a Clinical Trial Monitoring for both Intermediate and Primary Endpoints

scientific article published on May 2012

Adoptive immunotherapy by allogeneic stem cell transplantation for metastatic renal cell carcinoma: a CALGB intergroup phase II study.

scientific article published in July 2006

Adrenal androgen levels as predictors of outcome in prostate cancer patients treated with ketoconazole plus antiandrogen withdrawal: results from a cancer and leukemia group B study.

scientific article published in April 2007

Advancing Precision Oncology Through Biomarker-Driven Trials: Theory vs. Practice ⬇️

scholarly article

American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine

scientific article published on 19 January 2016

American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma

scientific article

Analgesic drug use and risk of ovarian cancer

scientific article (publication date: 2006)

Analysis of survival data with missing measurements of a time-dependent binary covariate.

scientific article

Androgen decline and survival during docetaxel therapy in metastatic castration resistant prostate cancer (mCRPC)

scientific article published on 03 May 2019

Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663.

scientific article

Androgens and Overall Survival in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Docetaxel

scientific article published on 17 October 2019

Anthropometric measurements and epithelial ovarian cancer risk in African-American and White women

scientific article published on 01 October 2005

Antiandrogen withdrawal alone or in combination with ketoconazole in androgen-independent prostate cancer patients: a phase III trial (CALGB 9583).

scientific article published in March 2004

Antidepressant medication use [corrected] and risk of ovarian cancer

scientific article published on 01 April 2005

Arsenic trioxide in recurrent urothelial cancer: a cancer and leukemia group B phase II trial (CALGB 99903).

scientific article

Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.

scientific article published on 10 February 2009

Association between family history of cancer and mutagen sensitivity in upper aerodigestive tract cancer patients ⬇️

scientific article published on 01 March 1993

Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality

scientific article published on 01 July 2019

Barriers to cardiac transplantation in idiopathic dilated cardiomyopathy: the Washington, DC, Dilated Cardiomyopathy Study

scientific article published on June 1, 1998

Best (but oft-forgotten) practices: sample size and power calculation for a dietary intervention trial with episodically consumed foods

scientific article published on 09 July 2020

Bevacizumab and everolimus in renal cancer: a rational way forward

scientific article published on 12 October 2010

Bevacizumab and the risk of arterial and venous thromboembolism in patients with metastatic, castration-resistant prostate cancer treated on Cancer and Leukemia Group B (CALGB) 90401 (Alliance).

scientific article

Bevacizumab plus interferon alfa compared with interferon alfa monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206

scientific article published on 20 October 2008

Biomarkers in the management and treatment of men with metastatic castration-resistant prostate cancer

scientific article

Breast cancer screening behaviors and attitudes in three racial/ethnic groups ⬇️

scientific article published on January 1, 1992

Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial.

scientific article

Cabozantinib Versus Sunitinib for Untreated Patients with Advanced Renal Cell Carcinoma of Intermediate or Poor Risk: Subgroup Analysis of the Alliance A031203 CABOSUN trial

scientific article published on 09 August 2019

Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update.

scientific article published on 15 March 2018

Can tailored interventions increase mammography use among HMO women?

scientific article published on 01 January 2000

Cancer and Leukemia Group B 90203 (Alliance): Radical Prostatectomy With or Without Neoadjuvant Chemohormonal Therapy in Localized, High-Risk Prostate Cancer

scientific article published on 24 July 2020

Cancer and Leukemia Group B 90206: A randomized phase III trial of interferon-alpha or interferon-alpha plus anti-vascular endothelial growth factor antibody (bevacizumab) in metastatic renal cell carcinoma

scientific article published in April 2004

Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

scientific article published on 22 October 2020

Challenges and Opportunities to Updating Prescribing Information for Longstanding Oncology Drugs

scientific article published on 08 December 2019

Circulating Tumor Cell Genomic Evolution and Hormone Therapy Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer

scientific article published on 26 March 2021

Circulating levels of inflammatory cytokines and risk of colorectal adenomas

scientific article published on January 2008

Clinical outcomes by age in men with hormone refractory prostate cancer: a pooled analysis of 8 Cancer and Leukemia Group B (CALGB) studies

scientific article published on 01 July 2006

Clinical phenotypes associated with circulating tumor cell enumeration in metastatic castration-resistant prostate cancer

scientific article published on 13 January 2015

Combination external beam radiation and brachytherapy boost with androgen deprivation for treatment of intermediate‐risk prostate cancer ⬇️

scientific article published on July 25, 2011

Combination external beam radiation and brachytherapy boost with androgen suppression for treatment of intermediate-risk prostate cancer: an initial report of CALGB 99809

scientific article published on 11 April 2008

Combination of Radiotherapy and Short-Term Androgen Blockade with Abiraterone Acetate plus Prednisone for Men with High and Intermediate Risk Localized Prostate Cancer

scientific article published on 28 November 2020

Combined Longitudinal Clinical and Autopsy Phenomic Assessment in Lethal Metastatic Prostate Cancer: Recommendations for Advancing Precision Medicine

scientific article published on 02 July 2021

Combined Performance of Screening and Variable Selection Methods in Ultra-High Dimensional Data in Predicting Time-To-Event Outcomes

scientific article published on 26 September 2018

Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With Docetaxel

scientific article published on 29 January 2020

Comparison of futility monitoring guidelines using completed phase III oncology trials

scientific article

Confusion about mammography: prevalence and consequences.

scientific article published in May 1999

Corrigendum to 'Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update

scientific article published on 27 September 2018

Critical Assessment of Clinical Prognostic Tools in Melanoma

scientific article

Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroup

scientific article published in March 2008

Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group

scientific article

Design issues in randomized phase II/III trials

scientific article published on 23 January 2012

Developing and Validating Risk Assessment Models of Clinical Outcomes in Modern Oncology

scientific article published on 24 October 2019

Discordant and heterogeneous clinically relevant genomic alterations in circulating tumor cells vs plasma DNA from men with metastatic castration resistant prostate cancer

scientific article published on 28 November 2019

Effects of a mammography decision-making intervention at 12 and 24 months.

scientific article published in May 2002

Efficacy of carboplatin-taxane combinations in the management of castration-resistant prostate cancer: a pooled analysis of seven prospective clinical trials

scientific article

Efficacy of peripheral androgen blockade in prostate cancer patients with biochemical failure after definitive local therapy: results of Cancer and Leukemia Group B (CALGB) 9782

scientific article published on 16 December 2011

Elevated body mass index predicts for longer overall survival duration in men with metastatic hormone-refractory prostate cancer

scientific article published on 01 April 2005

Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group

scientific article

Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group.

scientific article

Estimand framework: Are we asking the right questions? A case study in the solid tumor setting

scientific article published on 05 November 2020

Estimating historical atmospheric mercury concentrations from silver mining and their legacies in present-day surface soil in Potosí, Bolivia

article

Estimation and testing of the relative risk of disease in case-control studies with a set of k matched controls per case with known prevalence of disease.

scientific article published on 9 December 2011

Estimations of historical atmospheric mercury concentrations from mercury refining and present-day soil concentrations of total mercury in Huancavelica, Peru

scientific article published on 26 April 2012

Evaluation of an epithelial plasticity biomarker panel in men with localized prostate cancer.

scientific article published on 13 October 2015

Event-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation

scientific article published on 18 June 2020

Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial. ⬇️

scientific article

Evidence Synthesis to Accelerate and Improve the Evaluation of Therapies for Metastatic Hormone-sensitive Prostate Cancer

scientific article published on 01 February 2019

Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer

scientific article

Factors associated with perceived risk of breast cancer among women attending a screening program.

scientific article published in November 1993

Flexible Frames and Control Sampling in Case-Control Studies: Weighters (Survey Statisticians) Versus Anti-Weighters (Epidemiologists).

scientific article

Group-sequential logrank methods for trial designs using bivariate non-competing event-time outcomes

scientific article published on 12 April 2019

High Dimensional Variable Selection with Error Control

scientific article published on 15 August 2016

Higher doses of mitoxantrone among men with hormone-refractory prostate carcinoma: a Cancer and Leukemia Group B study.

scientific article

Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women

scientific article published on 25 February 2008

Hospital visitors as controls

scientific article published on 01 February 1988

Identification of a Genomic Region between and Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance)

scientific article published on 05 June 2018

Identification of women at increased risk for breast cancer in a population-based screening program ⬇️

scientific article published on January 1, 1992

Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer

scientific article

Impact of race on survival in men with metastatic hormone-refractory prostate cancer.

scientific article

Impact of therapy on genomics and transcriptomics in high-risk prostate cancer treated with neoadjuvant docetaxel and androgen deprivation therapy.

scientific article published on 25 August 2017

Improved Reporting in Abstracts When Uncertainty Is Inevitable

scientific article published on 02 December 2019

In Reply

In Reply

article published in 2008

Independent data monitoring committees: an update and overview

scientific article

Inverse correlation between body mass index and clinical outcomes in men with advanced castration-recurrent prostate cancer.

scientific article

Landscape of coronavirus disease 2019 clinical trials: New frontiers and challenges

scientific article published on 2 July 2022

Low incidence of familial breast cancer among Hispanic women

scientific article published on 01 July 1992

Making progress on progression in metastatic prostate cancer

scientific article published on 9 February 2015

Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019

scientific article published on 27 January 2020

Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017.

scientific article

Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.

scientific article published on 3 June 2015

Management of recurrent prostate cancer after radiotherapy: long-term results from CALGB 9687 (Alliance), a prospective multi-institutional salvage prostatectomy series

scientific article published on 01 November 2018

Maximizing the motivational impact of feedback of lung cancer susceptibility on smokers' desire to quit.

scientific article published in July 2000

Measurement of affective and activity pain interference using the Brief Pain Inventory (BPI): Cancer and Leukemia Group B 70903.

scientific article published on 30 October 2012

Menopausal hormones and risk of ovarian cancer

scientific article published on 01 July 2005

Mercury hair levels and factors that influence exposure for residents of Huancavelica, Peru.

scientific article published on 3 December 2014

Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer

scientific article

Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer

scientific article published on 10 August 2017

Multicenter phase 2 study of neoadjuvant paclitaxel, estramustine phosphate, and carboplatin plus androgen deprivation before radiation therapy in patients with unfavorable-risk localized prostate cancer: results of Cancer and Leukemia Group B 99811

scientific article

Mutagen sensitivity in upper aerodigestive tract cancer: a case-control analysis ⬇️

scientific article published on July 1, 1993

No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina

scientific article published in March 2003

On model specification and selection of the Cox proportional hazards model.

scientific article published on 19 June 2013

On the use of min-max combination of biomarkers to maximize the partial area under the ROC curve

scientific article published on 03 February 2019

Overall Survival of Black and White Men With Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel

scientific article published on 21 December 2018

Overview of bladder cancer trials in the Cancer and Leukemia Group B.

scientific article

Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States)

scientific article published on 01 November 2002

PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19)

scholarly article

PROMISE: a real-world clinical-genomic database to address knowledge gaps in prostate cancer

scientific article

Pain predicts overall survival in men with metastatic castration-refractory prostate cancer.

scientific article published on May 2008

Palbociclib (P) in patients (pts) with non-small cell lung cancer (NSCLC) with CDKN2A alterations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

scientific article

Palbociclib in Patients With Non–Small-Cell Lung Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study

scientific article

Pan-Cancer Prognostic Models: Statistical Exercise or Clinical Tools?

scientific article published on 03 September 2020

Perception of consanguineous marriages and their genetic effects among a sample of couples from beirut

article

Personalizing prognosis in colorectal cancer: A systematic review of the quality and nature of clinical prognostic tools for survival outcomes.

scientific article

Pharmacodynamic study of radium-223 in men with bone metastatic castration resistant prostate cancer.

scientific article

Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy

scientific article published on 3 May 2016

Phase 1b trial of docetaxel, prednisone, and pazopanib in men with metastatic castration-resistant prostate cancer

scientific article published on 09 September 2019

Phase 2 clinical trial of TORC1 inhibition with everolimus in men with metastatic castration-resistant prostate cancer

scientific article published on 12 September 2019

Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: a final report of CALGB 9780. Cancer and Leukemia Group B.

scientific article

Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia.

scientific article published in July 2004

Phase II trial of the PI3 kinase inhibitor buparlisib (BKM-120) with or without enzalutamide in men with metastatic castration resistant prostate cancer.

scientific article published on 11 May 2017

Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206

scientific article

Phase Ib Trial of Cabazitaxel and Tasquinimod in Men With Heavily Pretreated Metastatic Castration Resistant Prostate Cancer (mCRPC): The CATCH Trial.

scientific article published on 16 November 2016

Predictors of prostate cancer tissue acquisition by an undirected core bone marrow biopsy in metastatic castration-resistant prostate cancer--a Cancer and Leukemia Group B study

scientific article

Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers.

scientific article published in December 2004

Prognostic Significance of Plasma Scatter Factor/Hepatocyte Growth Factor Levels in Patients with Metastatic Hormone- Refractory Prostate Cancer: Results from Cancer and Leukemia Group B 150005/9480

scientific article published on 01 March 2006

Prognostic factors in early-onset epithelial ovarian cancer: a population-based study

scientific article published on 01 January 2000

Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer.

scientific article published in April 2003

Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy

scientific article published on 14 February 2013

Prognostic model predicting metastatic castration-resistant prostate cancer survival in men treated with second-line chemotherapy

scientific article published on 17 October 2013

Prognostic significance of plasma chromogranin a levels in patients with hormone-refractory prostate cancer treated in Cancer and Leukemia Group B 9480 study

scientific article published in August 2005

Prognostic significance of reverse transcriptase polymerase chain reaction for prostate-specific antigen in metastatic prostate cancer: a nested study within CALGB 9583.

scientific article

Progression-free survival as a predictor of overall survival in men with castrate-resistant prostate cancer.

scientific article published on 20 April 2009

Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic renal cell carcinoma

scientific article published on 08 October 2013

Progression-free survival: does a correlation with survival justify its role as a surrogate clinical endpoint?

scientific article

Prospective Multicenter Study of Circulating Tumor Cell AR-V7 and Taxane Versus Hormonal Treatment Outcomes in Metastatic Castration-Resistant Prostate Cancer

scientific article published on 28 October 2020

Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study

scientific article published on 13 March 2019

Prostate Cancer Foundation Hormone-Sensitive Prostate Cancer Biomarker Working Group Meeting Summary

scientific article published on 26 December 2020

Prostate-specific antigen changes as surrogate for overall survival in men with metastatic castration-resistant prostate cancer treated with second-line chemotherapy

scientific article published on 07 October 2013

Randomized controlled trial of early zoledronic acid in men with castration-sensitive prostate cancer and bone metastases: results of CALGB 90202 (alliance).

scientific article published on 03 March 2014

Randomized study of three different doses of suramin administered with a fixed dosing schedule in patients with advanced prostate cancer: results of intergroup 0159, cancer and leukemia group B 9480.

scientific article published in August 2002

Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401.

scientific article

Rationale and Design of the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

scientific article published on 11 July 2018

Refining Prognosis in Lung Cancer: A Report on the Quality and Relevance of Clinical Prognostic Tools

scientific article

Reliability and validity of self and proxy reporting of morbidity data: a case study from Beirut, Lebanon

scientific article published on June 1, 1992

Reply to B. Rini et al and S. Buti et al.

scientific article

Reply to F. Valcamonico et al.

scientific article

Reply to L. Dirix, B. De Laere et al, and A. Sharp et al

scientific article published on 02 July 2019

Reply to M A Khattak et al.

scientific article published in March 2013

Residential mercury contamination in adobe brick homes in Huancavelica, Peru.

scientific article

Residential metal contamination and potential health risks of exposure in adobe brick houses in Potosí, Bolivia.

scientific article published on 18 April 2016

Role of Bone-Modifying Agents in Multiple Myeloma: American Society of Clinical Oncology Clinical Practice Guideline Update

scientific article published on 17 January 2018

Sample Size Requirements and Study Duration for Testing Main Effects and Interactions in Completely Randomized Factorial Designs When Time to Event is the Outcome.

scientific article

Sample size determination for comparing several survival curves with unequal allocations.

scientific article published in June 2004

Score and deviance residuals based on the full likelihood approach in survival analysis

scientific article published on 09 August 2020

Second-line chemotherapy for advanced hormone-refractory prostate cancer

scientific article published on February 2008

Serum lactate dehydrogenase predicts for overall survival benefit in patients with metastatic renal cell carcinoma treated with inhibition of mammalian target of rapamycin.

scientific article published on 13 August 2012

Statistical considerations for the design and analysis of Phase III clinical trials in prostate cancer.

scientific article

Sunitinib in Patients with Metastatic Colorectal Cancer (mCRC) with FLT-3 Amplification: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

scientific article published on 17 October 2020

The COMPARE Registry: design and baseline patterns of care for men with biochemical failure after definitive treatment of localized prostate cancer

scientific article published on 08 July 2009

The Development of Intermediate Clinical Endpoints in Cancer of the Prostate (ICECaP).

scientific article published on 25 September 2015

The Texas Breast Screening Project: Part I. Mammographic and clinical results

scientific article published on 01 April 1993

The Texas Breast Screening Project: Part II. Demographics, risk profiles, and health practices of participants.

scientific article published in April 1993

The development of risk groups in men with metastatic castration-resistant prostate cancer based on risk factors for PSA decline and survival

scientific article published on 11 December 2009

The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90

scientific article published on 31 July 2013

The impact of abnormal mammograms on psychosocial outcomes and subsequent screening

scientific article published on 01 September 2000

The impact of prior radical prostatectomy in men with metastatic castration recurrent prostate cancer: a pooled analysis of 9 Cancer and Leukemia Group B Trials

scientific article published on 01 February 2007

The importance of identifying and validating prognostic factors in oncology.

scientific article

The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: results from cancer and leukemia group B 9480.

scientific article

The relationship of body mass index and serum testosterone with disease outcomes in men with castration-resistant metastatic prostate cancer.

scientific article published on 24 June 2008

Transforming growth factor beta receptor I polyalanine repeat polymorphism does not increase ovarian cancer risk.

scientific article published in May 2005

Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

scientific article

Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer.

scientific article published in March 2007

Tumor volume changes on 1.5 tesla endorectal MRI during neoadjuvant androgen suppression therapy for higher-risk prostate cancer and recurrence in men treated using radiation therapy results of the phase II CALGB 9682 study

scientific article

Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancer.

scientific article published on 21 January 2014

Use of nonsteroidal antiinflammatory drugs and distal large bowel cancer in whites and African Americans

scientific article published on 21 October 2008

Validation of a breast cancer risk assessment model in women with a positive family history.

scientific article published in April 1994

Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: Final results from CALGB trial 79809 ⬇️

scientific article published on February 14, 2011

p53 protein expression status and recurrence in men treated with radiation and androgen suppression therapy for higher-risk prostate cancer: a prospective phase II Cancer and Leukemia Group B Study (CALGB 9682).

scientific article

Paulina is supported by:

About Paulina

Help